SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital
Abstract
:1. Introduction
2. Materials and Methods
2.1. Samples
2.2. Methods
2.3. Statistic
3. Results
3.1. Seroprevalence
3.2. IgG Titration
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Rolling Updates on Coronavirus Disease (COVID-19): WHO Characterizes COVID-19 as a Pandemic. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen (accessed on 14 May 2020).
- WHO Coronavirus Disease (COVID-19) Dashboard. Available online: https://covid19.who.int/ (accessed on 8 June 2020).
- Wang, W.; Xu, Y.; Gao, R.; Lu, R.; Han, K.; Wu, G.; Tan, W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA 2020. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- To, K.K.-W.; Tsang, O.T.-Y.; Leung, W.-S.; Tam, A.R.; Wu, T.-C.; Lung, D.C.; Yip, C.C.-Y.; Cai, J.-P.; Chan, J.M.-C.; Chik, T.S.-H.; et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study. Lancet Infect. Dis. 2020, 20, 565–574. [Google Scholar] [CrossRef] [Green Version]
- Lou, B.; Li, T.; Zheng, S.; Su, Y.; Li, Z.; Liu, W.; Yu, F.; Ge, S.; Zou, Q.; Yuan, Q.; et al. Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset; Infectious Diseases (except HIV/AIDS). Eur. Respir. J. 2020. [Google Scholar] [CrossRef] [PubMed]
- Grzelak, L.; Temmam, S.; Planchais, C.; Demeret, C.; Huon, C.; Guivel, F.; Staropoli, I.; Chazal, M.; Dufloo, J.; Planas, D.; et al. SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Shields, A.M.; Faustini, S.E.; Perez-Toledo, M.; Jossi, S.; Aldera, E.L.; Allen, J.D.; Al-Taei, S.; Backhouse, C.; Bosworth, A.; Dunbar, L.; et al. SARS-CoV-2 seroconversion in health care workers; Allergy and Immunology. MedRxiv 2020. [Google Scholar] [CrossRef]
- Corso, G.; Cristofano, A.; Sapere, N.; la Marca, G.; Angiolillo, A.; Vitale, M.; Fratangelo, R.; Lombardi, T.; Porcile, C.; Intrieri, M.; et al. Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia. Dement. Geriatr. Cogn. Disord. Extra 2017, 7, 143–159. [Google Scholar] [CrossRef] [PubMed]
- Gelzo, M.; Sica, C.; Elce, A.; Dello Russo, A.; Iacotucci, P.; Carnovale, V.; Raia, V.; Salvatore, D.; Corso, G.; Castaldo, G. Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: A preliminary study of plasma sterols. Clin. Chem. Lab. Med. 2016, 54, 1461–1466. [Google Scholar] [CrossRef] [PubMed]
- Xu, X.; Sun, J.; Nie, S.; Li, H.; Kong, Y.; Liang, M.; Hou, J.; Huang, X.; Li, D.; Ma, T.; et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat. Med. 2020. [Google Scholar] [CrossRef] [PubMed]
- Valenti, L.; Bergna, A.; Pelusi, S.; Facciotti, F.; Lai, A.; Tarkowski, M.; Berzuini, A.; Caprioli, F.; Santoro, L.; Baselli, G.; et al. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak. MedRxiv 2020. [Google Scholar] [CrossRef]
- Korth, J.; Wilde, B.; Dolff, S.; Anastasiou, O.E.; Krawczyk, A.; Jahn, M.; Cordes, S.; Ross, B.; Esser, S.; Lindemann, M.; et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J. Clin. Virol. 2020, 128, 104437. [Google Scholar] [CrossRef] [PubMed]
- Behrens, G.M.N.; Cossmann, A.; Stankov, M.V.; Witte, T.; Ernst, D.; Happle, C.; Jablonka, A. Perceived versus proven SARS-CoV-2-specific immune responses in healthcare professionals. Infection 2020. [Google Scholar] [CrossRef] [PubMed]
- Sood, N.; Simon, P.; Ebner, P.; Eichner, D.; Reynolds, J.; Bendavid, E.; Bhattacharya, J. Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10–11, 2020. JAMA 2020. [Google Scholar] [CrossRef] [PubMed]
- Long, Q.-X.; Tang, X.-J.; Shi, Q.-L.; Li, Q.; Deng, H.-J.; Yuan, J.; Hu, J.-L.; Xu, W.; Zhang, Y.; Lv, F.-J.; et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 2020, 26, 1200–1204. [Google Scholar] [CrossRef] [PubMed]
- Zhao, D.; Wang, M.; Wang, M.; Zhao, Y.; Zheng, Z.; Li, X.; Zhang, Y.; Wang, T.; Zeng, S.; Hu, W.; et al. Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China. Int. J. Infect. Dis. 2020, 99, 219–225. [Google Scholar] [CrossRef] [PubMed]
Smart Working Offices | Other Departments | ER | ICU | Pneumology Unit | Infectious Diseases | Laboratory | Total Employees | Pre-COVID-19 | ||
---|---|---|---|---|---|---|---|---|---|---|
No. (%) | 78 (2.2) | 2736 (84.4) | 96 (2.9) | 100 (3) | 90 (2.7) | 57 (1.7) | 85 (2.6) | 3242 | 83 | |
Age | Mean (±SD) | 51.3 (9.1) | 46.7 (11.6) | 43.1 (12.3) | 38.8 (9.6) | 43.7 (12.6) | 41.6 (14.6) | 48.9 (10.2) | 46.5 (11.7) | 49 (14.8) |
IgG, AU/mL | Mean (±SD) | 0.68 (0.98) | 1.28 (6.96) | 0.62 (0.66) | 0.78 (1.27) | 0.86 (1.51) | 0.74 (0.72) | 2.27 (14.13) | 1.14 (6.12) | 0.72 (0.92) |
Min–Max | 0.07–5.85 | 0.05–131.00 | 0.11–4.7 | 0.10–11.22 | 0.11–12.84 | 0.13–3.73 | 0.09–131.62 | 0.05–131.62 | 0.11–5.36 | |
Positive tests | 0 | 34 | 0 | 1 | 1 | 0 | 1 | 37 | 0 | |
IgM, AU/mL | Mean (±SD) | 0.80 (1.30) | 1.07 (4.79) | 1.36 (3.74) | 1.39 (1.47) | 1.14 (2.67) | 1.23 (1.20) | 1.06 (1.13) | 1.04 (4.31) | 0.88 (0.82) |
Min–Max | 0.26–9.04 | 0.16–186.39 | 0.22–36.59 | 0.22–8.57 | 0.15–24.62 | 0.26–6.36 | 0.22–8.46 | 0.15–186.39 | 0.25–5.72 | |
Positive tests | 1 | 25 | 1 | 1 | 1 | 0 | 1 | 30 | 0 | |
Positive subjects | 1 | 55 | 1 | 2 | 2 | 0 | 1 | 62 | 0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
De Carlo, A.; Lo Caputo, S.; Paolillo, C.; Rosa, A.M.; D’Orsi, U.; De Palma, M.; Reveglia, P.; Lacedonia, D.; Cinnella, G.; Foschino, M.P.; et al. SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital. Int. J. Environ. Res. Public Health 2020, 17, 9324. https://doi.org/10.3390/ijerph17249324
De Carlo A, Lo Caputo S, Paolillo C, Rosa AM, D’Orsi U, De Palma M, Reveglia P, Lacedonia D, Cinnella G, Foschino MP, et al. SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital. International Journal of Environmental Research and Public Health. 2020; 17(24):9324. https://doi.org/10.3390/ijerph17249324
Chicago/Turabian StyleDe Carlo, Armando, Sergio Lo Caputo, Carmela Paolillo, Anna Maria Rosa, Umberto D’Orsi, Maria De Palma, Pierluigi Reveglia, Donato Lacedonia, Gilda Cinnella, Maria Pia Foschino, and et al. 2020. "SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital" International Journal of Environmental Research and Public Health 17, no. 24: 9324. https://doi.org/10.3390/ijerph17249324